Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-10-17 00:00:00 ET · period of report 2023-10-13 · accession 0001870913-23-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-10-17 | 2023-10-13+ | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $57.96 | -25.0K | 1.06M | -2% | -$1.45M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-13 | S | D | 11,937 | $57.58 | 1,070,683 | I Held by Esjay LLC | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.36 to $58.00, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| 2 | Common | Common Stock | 2023-10-16 | S | D | 13,063 | $58.31 | 1,057,620 | I Held by Esjay LLC | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.75 to $58.88, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |